Search results
Coexistence of psoriatic arthritis, atopic dermatitis may offer treatment insights
Medical Xpress· 16 hours agoPsoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both...
Sketchy stem-cell treatments in Mexico led to drug-resistant infections
Live Science via Yahoo News· 1 day agoThe injections were reportedly intended to treat the autoimmune disease multiple sclerosis, for...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Rome Sentinel· 5 days agoAdalimumab-aaty is also available from Celltrion USA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty ...
Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infections - UPI.com
UPI· 6 days agoThe cases outlined in the new report began in late 2022, when a Colorado woman in her 30s showed up...
Amgen Inc. (AMGN) To Go Ex-Dividend on May 16th
ETF DAILY NEWS· 24 hours agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) announced a quarterly dividend on Wednesday, March 6th, RTT News reports. This represents a $9.00 annualized dividend and a dividend yield of 2.92% ...
Stem Cell Injections in Mexico Led to Drug-Resistant Infections
MedPage Today· 6 days agoThree patients developed difficult-to-treat Mycobacterium abscessus infections after receiving...
Three drug-resistant infections in US tied to stem-cell injections in Mexico
Center for Infectious Disease Research and Policy· 5 days agoThe first (patient B) was a man from Arizona who developed a right elbow osteoarticular infection...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 5 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 5 days agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 3 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the stock, MarketBeat ...